Union Bancaire Privee’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10
Closed -$3.21K 551
2024
Q4
$3.21K Buy
+10
New +$478 ﹤0.01% 552

Other funds holding MRNA

Union Bancaire Privee's MRNA Position: Q2 2026 in Review

Union Bancaire Privee increased its Moderna (MRNA) stake by 7,500% in Q2 2026, buying an estimated $776K and bringing the position to 15,200 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #294.

Union Bancaire Privee first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.45M in Q4 2024. 305 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Union Bancaire Privee held 15,200 shares of Moderna worth $1.06M as of Q2 2026.
  • Union Bancaire Privee bought 15,000 Moderna shares in Q2 2026, an estimated $776K.
  • Moderna made up 0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #294 holding.
  • Union Bancaire Privee first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • Union Bancaire Privee's Moderna position peaked at $1.45M in Q4 2024.
  • 305 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.